$ 15,900 plus shipping
HP Printer included 30 trial available
MetriScan lets the primary care physician screen patients' bone mineral density (BMD) during a routine office exam. This type of test typically requires a visit to the hospital imaging center for a Central DEXA examination.?
Physicians now have a front line diagnostic tool that will help them identify patients who may have low BMD and be at risk for osteoporotic fractures. Using a one minute procedure that scans the patient's hand, physicians can assess osteoporosis risk. This is critically important today, as osteoporosis was recently determined to be significantly underdiagnosed.
Indications for Use MetriScan is indicated for use in estimating relative bone mineral density (BMD).? The estimate of relative BMD and T-score may be used as an aid to the physician in assessing fracture risk, and for monitoring changes in bone mass over time.
Who should have Bone Mineral Density (BMD) testing?
Perimenopausal women with risk factors for osteoporosis, including cigarette smoking or corticosteroid use.
Postmenopausal women who are undecided regarding hormonal replacement therapy or use of other drugs to prevent/treat osteoporosis.
Postmenopausal women under age 65 who have one or more additional risk factors for osteoporotic fracture (besides menopause).
All women aged 65 and older regardless of additional risk factors.
Postmenopausal women who present with fractures or evidence of reduced BMD on plain x-ray (to confirm diagnosis and determine disease severity).
Women being monitored during treatment of osteoporosis.
Men and women under treatment for conditions where the medication may affect BMD.
MetriScan uses radiographic absorptiometry (RA) to estimate relative phalangeal bone density of the three middle fingers. With RA a high resolution radiographic image of a patient's phalanges is taken. A computerized analysis is made comparing the intensity of the image with a reference wedge embedded under the hand plate.
Validation This method was validated in one of the largest epidemiological studies in the bone density field*. Phalangeal bone density testing was performed on 3481 women, who were then followed for sixteen years. The study concluded that phalageal bone densitometry is a significant predictor of future hip fractures.?
Features ? 0.3?second scan time
? Radiation dose is less than 5% of a dental x-ray
? Precision error = 1.1%
? Automatic calibration check
? Small footprint:? 16" x 16" x 16"
MetriScan lets the primary care physician screen patients' bone mineral density (BMD) during a routine office exam. This type of test typically requires a visit to the hospital imaging center for a Central DEXA examination.? 
